AlphaCrest Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

AlphaCrest Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,724	Closed	-$1.03M	–	827
2022 Q3	$1.03M	Sell	20,724 -20,018	-49%	-$1.11M	0.06%	586
2022 Q2	$2.4M	Sell	40,742 -16,392	-29%	-$904K	0.12%	243
2022 Q1	$3.02M	Buy	57,134 +28,702	+101%	+$1.66M	0.17%	124
2021 Q4	$1.72M	Sell	28,432 -18,228	-39%	-$1.08M	0.06%	508
2021 Q3	$2.62M	Buy	+46,660	New	+$2.56M	0.14%	194
2020 Q1	–	Sell	-9,214	Closed	-$373K	–	1209
2019 Q4	$373K	Sell	9,214 -683	-7%	-$25.5K	0.03%	951
2019 Q3	$343K	Sell	9,897 -501	-5%	-$16.5K	0.02%	1064
2019 Q2	$329K	Buy	+10,398	New	+$309K	0.03%	835

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's PBH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 20,724 shares — an estimated $1.03M sold.

AlphaCrest Capital Management first reported a position in PBH in Q2 2019 and held it in 8 quarters. The position peaked at $3.02M in Q1 2022. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

AlphaCrest Capital Management reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 20,724 Prestige Consumer Healthcare shares in Q4 2022, an estimated $1.03M.
AlphaCrest Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2019 and held it in 8 quarters.
AlphaCrest Capital Management's Prestige Consumer Healthcare position peaked at $3.02M in Q1 2022.
289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.